
|Articles|October 1, 2012
- Applied Clinical Trials-10-01-2012
- Volume 21
- Issue 10
Applied Clinical Trials Digital Edition - October 2012
CRO/SPONSOR : Outsourcing to China REGULATORY : Warning Letter Analysis CRO/SPONSOR : Customer Expectation Management Also in this issue : EU Pediatric Regulation, Healthcare Data Informs Research, Modeling and Simulation
Advertisement
Articles in this issue
about 13 years ago
Business and News Update October 2012about 13 years ago
Virtual Trials Come Under Growing Scrutinyabout 13 years ago
EDC Autoquery Rate - A Marker for Site Qualityabout 13 years ago
Warning Letter Studyabout 13 years ago
Diagnostics Needed for Personalized Medicineabout 13 years ago
Research, Practice, and Learningabout 13 years ago
The Local Touchabout 13 years ago
Managing Customer Expectationsabout 13 years ago
Act Coverabout 13 years ago
Site-Cost Line Item Charges on the RiseNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Utilizing Tech Tools to Accelerate Drug Development
3
Streamlining Clinical Data to Reduce Site and Participant Burden
4
ACT Brief: Lilly Seeks FDA Priority Review for Oral GLP-1 as Bispecific Antibody Trials Redefine Ethical Standards
5






.png)



.png)



.png)
.png)
